Scan-associated distress in lung cancer: Quantifying the impact of “scanxiety”

Joshua M. Bauml, Andrea Troxel, C. Neill Epperson, Roger B. Cohen, Kathryn Schmitz, Carrie Stricker, Lawrence N. Shulman, Angela Bradbury, Jun J. Mao, Corey J. Langer

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objectives Diagnostic imaging may be a major source of cancer-related distress, a condition known as “scanxiety”. Scant scholarly work has been performed to evaluate scan-associated distress in cancer. We sought to characterize risk factors for scan-associated distress among patients with Non-Small Cell Lung Cancer (NSCLC), and to evaluate the impact of scan-associated distress on quality of life. Materials and methods We conducted a cross-sectional survey study of patients with recurrent/metastatic NSCLC treated at an academic medical center. Clinical and demographic variables were obtained through chart abstraction and patient self-report. We used a modified version of the Impact of Event Scale 6 (IES-6) to specifically assess distress associated with scans, and quality of life was measured using the Functional Assessment of Cancer Therapy − Lung (FACT-L). Results Among 103 participants (survey response rate 76.3%), median age was 67, 61.2% were women, and 82.5% were white. At the study visit, 72.8% of subjects discussed a recent scan, and 83% reported some scan-associated distress. Scan-associated distress was not associated with whether the patient had a recent scan, progressive disease or time from diagnosis. Scan-associated distress was associated with impaired quality of life (p = 0.004); each unit increase in IES-6 corresponded to an approximately one-unit decrease in FACT-L score. Conclusion Scan-associated distress is a common problem among patients with NSCLC, and is associated with impaired quality of life. Scan-associated distress severity was not associated with time since diagnosis or whether a recent scan was discussed at the study visit, which implies scan-associated distress may be a persistent problem.

Original languageEnglish (US)
Pages (from-to)110-113
Number of pages4
JournalLung Cancer
Volume100
DOIs
StatePublished - Oct 1 2016

Fingerprint

Lung Neoplasms
Quality of Life
Non-Small Cell Lung Carcinoma
Cross-Sectional Studies
Diagnostic Imaging
Self Report
Neoplasms
Demography
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Bauml, J. M., Troxel, A., Epperson, C. N., Cohen, R. B., Schmitz, K., Stricker, C., ... Langer, C. J. (2016). Scan-associated distress in lung cancer: Quantifying the impact of “scanxiety”. Lung Cancer, 100, 110-113. https://doi.org/10.1016/j.lungcan.2016.08.002
Bauml, Joshua M. ; Troxel, Andrea ; Epperson, C. Neill ; Cohen, Roger B. ; Schmitz, Kathryn ; Stricker, Carrie ; Shulman, Lawrence N. ; Bradbury, Angela ; Mao, Jun J. ; Langer, Corey J. / Scan-associated distress in lung cancer : Quantifying the impact of “scanxiety”. In: Lung Cancer. 2016 ; Vol. 100. pp. 110-113.
@article{21691c3b68664e418b494a94fc000019,
title = "Scan-associated distress in lung cancer: Quantifying the impact of “scanxiety”",
abstract = "Objectives Diagnostic imaging may be a major source of cancer-related distress, a condition known as “scanxiety”. Scant scholarly work has been performed to evaluate scan-associated distress in cancer. We sought to characterize risk factors for scan-associated distress among patients with Non-Small Cell Lung Cancer (NSCLC), and to evaluate the impact of scan-associated distress on quality of life. Materials and methods We conducted a cross-sectional survey study of patients with recurrent/metastatic NSCLC treated at an academic medical center. Clinical and demographic variables were obtained through chart abstraction and patient self-report. We used a modified version of the Impact of Event Scale 6 (IES-6) to specifically assess distress associated with scans, and quality of life was measured using the Functional Assessment of Cancer Therapy − Lung (FACT-L). Results Among 103 participants (survey response rate 76.3{\%}), median age was 67, 61.2{\%} were women, and 82.5{\%} were white. At the study visit, 72.8{\%} of subjects discussed a recent scan, and 83{\%} reported some scan-associated distress. Scan-associated distress was not associated with whether the patient had a recent scan, progressive disease or time from diagnosis. Scan-associated distress was associated with impaired quality of life (p = 0.004); each unit increase in IES-6 corresponded to an approximately one-unit decrease in FACT-L score. Conclusion Scan-associated distress is a common problem among patients with NSCLC, and is associated with impaired quality of life. Scan-associated distress severity was not associated with time since diagnosis or whether a recent scan was discussed at the study visit, which implies scan-associated distress may be a persistent problem.",
author = "Bauml, {Joshua M.} and Andrea Troxel and Epperson, {C. Neill} and Cohen, {Roger B.} and Kathryn Schmitz and Carrie Stricker and Shulman, {Lawrence N.} and Angela Bradbury and Mao, {Jun J.} and Langer, {Corey J.}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.lungcan.2016.08.002",
language = "English (US)",
volume = "100",
pages = "110--113",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",

}

Bauml, JM, Troxel, A, Epperson, CN, Cohen, RB, Schmitz, K, Stricker, C, Shulman, LN, Bradbury, A, Mao, JJ & Langer, CJ 2016, 'Scan-associated distress in lung cancer: Quantifying the impact of “scanxiety”', Lung Cancer, vol. 100, pp. 110-113. https://doi.org/10.1016/j.lungcan.2016.08.002

Scan-associated distress in lung cancer : Quantifying the impact of “scanxiety”. / Bauml, Joshua M.; Troxel, Andrea; Epperson, C. Neill; Cohen, Roger B.; Schmitz, Kathryn; Stricker, Carrie; Shulman, Lawrence N.; Bradbury, Angela; Mao, Jun J.; Langer, Corey J.

In: Lung Cancer, Vol. 100, 01.10.2016, p. 110-113.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Scan-associated distress in lung cancer

T2 - Quantifying the impact of “scanxiety”

AU - Bauml, Joshua M.

AU - Troxel, Andrea

AU - Epperson, C. Neill

AU - Cohen, Roger B.

AU - Schmitz, Kathryn

AU - Stricker, Carrie

AU - Shulman, Lawrence N.

AU - Bradbury, Angela

AU - Mao, Jun J.

AU - Langer, Corey J.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Objectives Diagnostic imaging may be a major source of cancer-related distress, a condition known as “scanxiety”. Scant scholarly work has been performed to evaluate scan-associated distress in cancer. We sought to characterize risk factors for scan-associated distress among patients with Non-Small Cell Lung Cancer (NSCLC), and to evaluate the impact of scan-associated distress on quality of life. Materials and methods We conducted a cross-sectional survey study of patients with recurrent/metastatic NSCLC treated at an academic medical center. Clinical and demographic variables were obtained through chart abstraction and patient self-report. We used a modified version of the Impact of Event Scale 6 (IES-6) to specifically assess distress associated with scans, and quality of life was measured using the Functional Assessment of Cancer Therapy − Lung (FACT-L). Results Among 103 participants (survey response rate 76.3%), median age was 67, 61.2% were women, and 82.5% were white. At the study visit, 72.8% of subjects discussed a recent scan, and 83% reported some scan-associated distress. Scan-associated distress was not associated with whether the patient had a recent scan, progressive disease or time from diagnosis. Scan-associated distress was associated with impaired quality of life (p = 0.004); each unit increase in IES-6 corresponded to an approximately one-unit decrease in FACT-L score. Conclusion Scan-associated distress is a common problem among patients with NSCLC, and is associated with impaired quality of life. Scan-associated distress severity was not associated with time since diagnosis or whether a recent scan was discussed at the study visit, which implies scan-associated distress may be a persistent problem.

AB - Objectives Diagnostic imaging may be a major source of cancer-related distress, a condition known as “scanxiety”. Scant scholarly work has been performed to evaluate scan-associated distress in cancer. We sought to characterize risk factors for scan-associated distress among patients with Non-Small Cell Lung Cancer (NSCLC), and to evaluate the impact of scan-associated distress on quality of life. Materials and methods We conducted a cross-sectional survey study of patients with recurrent/metastatic NSCLC treated at an academic medical center. Clinical and demographic variables were obtained through chart abstraction and patient self-report. We used a modified version of the Impact of Event Scale 6 (IES-6) to specifically assess distress associated with scans, and quality of life was measured using the Functional Assessment of Cancer Therapy − Lung (FACT-L). Results Among 103 participants (survey response rate 76.3%), median age was 67, 61.2% were women, and 82.5% were white. At the study visit, 72.8% of subjects discussed a recent scan, and 83% reported some scan-associated distress. Scan-associated distress was not associated with whether the patient had a recent scan, progressive disease or time from diagnosis. Scan-associated distress was associated with impaired quality of life (p = 0.004); each unit increase in IES-6 corresponded to an approximately one-unit decrease in FACT-L score. Conclusion Scan-associated distress is a common problem among patients with NSCLC, and is associated with impaired quality of life. Scan-associated distress severity was not associated with time since diagnosis or whether a recent scan was discussed at the study visit, which implies scan-associated distress may be a persistent problem.

UR - http://www.scopus.com/inward/record.url?scp=84989847833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989847833&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2016.08.002

DO - 10.1016/j.lungcan.2016.08.002

M3 - Article

C2 - 27597289

AN - SCOPUS:84989847833

VL - 100

SP - 110

EP - 113

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

ER -